PREDICT is a project coordinated by the Maastricht University that aims at training a new generation of early stage researchers to become leaders in the field of Radiomics and personalised medicine, ultimately aimed at improving the diagnosis and treatment of cancer.
The PREDICT project has received €3.86 million to train the next generation of scientists that will introduce radiomics technology for personalized cancer treatment.
PREDICT is the Marie-Sklodowska-Curie Innovative Training Network in the field of radiomics and personalized medicine.
The Marie Skłodowska-Curie actions support researchers at all stages of their careers, regardless of age and nationality. Researchers working across all disciplines are eligible for funding. The MSCA also support cooperation between industry and academia and innovative training to enhance employability and career development.
The Innovative Training Networks
The Innovative Training Networks aim to train a new generation of creative, entrepreneurial and innovative early-stage researchers, able to face current and future challenges and to convert knowledge and ideas into products and services for economic and social benefit.
ECPC will take part in the Marie Curie Innovative Training Network ‘PREDICT’ as a partner organisation. We will contribute to the training courses by offering our expertise in patient involvement as well as advocating the role of patients/co-researchers as the best partnership model between researchers and patients, since it allows patients to contribute with their unique experience to key decisions regarding research projects. We will also take place in the Project Advisory Board to monitoring the project progress and use our communication channels to advertise the project, its results and participants. provide input on the design and direction of the ESR projects.
PREDICT is funded by Horizon 2020: the European Union Framework Programme for Research and Innovation.